Datasets
12 results
Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice
(11) 中國醫藥大學附設醫院消化醫學中心 - 林肇堂醫師團隊
PRJNA379878, Diet and exercise are conventional methods for controlling body weight and are linked to alterations in gut microbiota. However, the associations of diet, exercise, and gut microbiota in the control of obesity remain largely unknown...
Mouse gut microbiota raw sequence reads
(01) 國立陽明大學生物醫學資訊研究所 - 吳俊穎醫師團隊
The project aims to study the effects of diet, exercises and fmt on body weights using mouse model.
Mus musculus intestinal transcriptome and microbiome in diet-induced obesity
(07) 財團法人國家衛生研究院免疫醫學研究中心 - 高承源教授團隊
The intestinal transcriptome and microbiome of dusp6 knockout and wild-type control mice in the C57BL/6 background were compared.
16S microbiome of Mus musculus: fecal DNA from 8-10 weeks old wild type and Dusp6 knockout
(07) 財團法人國家衛生研究院免疫醫學研究中心 - 高承源教授團隊
1. 16S microbiome of Mus musculus: fecal DNA from 8-9 weeks old wild type male (Water, T0) 2. 16S microbiome of Mus musculus: fecal DNA from 8-9 weeks old Dusp6 knockout male (Water, T0) 3. 16S microbiome of Mus musculus: fecal DNA from 9-10...
連續性母乳檢體93個 (31位)
(08) 國立成功大學醫學系小兒科 - 楊燿榮醫師團隊
Human, 16Sr RNA, V3-V4, Miseq, Maternal, exclusive breastfeeding
母嬰檢體配對257個 (口腔、鼻腔、糞便、母乳)
(08) 國立成功大學醫學系小兒科 - 楊燿榮醫師團隊
母嬰檢體配對(口腔、鼻腔、糞便、母乳) 257組 描述：Human, 16Sr RNA, V3-V4, Miseq, Maternal, Infant
Mouse gut metagenome of HFD mice after receiving Ganoderma lucidum treated fecal transplant
(06) 長庚大學醫學生物技術暨檢驗學系 - 賴信志教授團隊
To exmine whether the anti-obesity effect of Ganoderma lucidum is transmissible via fecal transplanation
Gut microbiota of CRC patients with or without diarrhea after irinotecan treatment-28
(10) 高雄醫學大學臨床醫學研究所 - 王照元醫師團隊
The gut microbiome of colorectal cancer patients with or without diarrhea after irinotecan treatment were compared.
Gut microbiota of CRC patients with or without responses to irinotecan treatment-15
(10) 高雄醫學大學臨床醫學研究所 - 王照元醫師團隊
The gut microbiome of colorectal cancer patients with or without responses to irinotecan treatment were compared.